Selected research
Industry Research
Animal Parvovirus Vaccine Industry Research Report 2026
Market perspective
The global Animal Parvovirus Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal Parvovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal Parvovirus Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal Parvovirus Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal Parvovirus Vaccine include China Animal Husbandy Industry, Ringpu Bio-technology, Qilu Animal Health Products, Pulike Biological, Keqian Biology, Hile Biological, Harbin Pharmaceutical Group, DHN and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal Parvovirus Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Parvovirus Vaccine Market by Company
China Animal Husbandy Industry
Ringpu Bio-technology
Qilu Animal Health Products
Pulike Biological
Keqian Biology
Hile Biological
Harbin Pharmaceutical Group
DHN
Zoetis
Virbac
Merck Animal Health
HIPRA
Elanco
Ceva Animal Health
Boehringer Ingelheim
Bioveta
Animal Parvovirus Vaccine Segment by Type
Individual Vaccine
Combination Vaccine
Animal Parvovirus Vaccine Segment by Application
Porcine
Canine
Feline
Others
Animal Parvovirus Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Parvovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Parvovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Parvovirus Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal Parvovirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal Parvovirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Individual Vaccine
- Combination Vaccine
Applications
- Porcine
- Canine
- Feline
- Others
Companies covered
- China Animal Husbandy Industry
- Ringpu Bio-technology
- Qilu Animal Health Products
- Pulike Biological
- Keqian Biology
- Hile Biological
- Harbin Pharmaceutical Group
- DHN
- Zoetis
- Virbac
- Merck Animal Health
- HIPRA
- Elanco
- Ceva Animal Health
- Boehringer Ingelheim
- Bioveta
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal Parvovirus Vaccine Market Size (2021-2032)
- 2.2.2 Global Animal Parvovirus Vaccine Sales (2021-2032)
- 2.2.3 Global Animal Parvovirus Vaccine Market Average Price (2021-2032)
- 2.3 Animal Parvovirus Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Individual Vaccine
- 2.3.3 Combination Vaccine
- 2.4 Animal Parvovirus Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Porcine
- 2.4.3 Canine
- 2.4.4 Feline
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal Parvovirus Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal Parvovirus Vaccine Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Animal Parvovirus Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal Parvovirus Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal Parvovirus Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal Parvovirus Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal Parvovirus Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Animal Parvovirus Vaccine, Established Date
- 3.9 Global Animal Parvovirus Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 China Animal Husbandy Industry
- 4.1.1 China Animal Husbandy Industry Company Information
- 4.1.2 China Animal Husbandy Industry Business Overview
- 4.1.3 China Animal Husbandy Industry Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 China Animal Husbandy Industry Animal Parvovirus Vaccine Product Portfolio
- 4.1.5 China Animal Husbandy Industry Recent Developments
- 4.2 Ringpu Bio-technology
- 4.2.1 Ringpu Bio-technology Company Information
- 4.2.2 Ringpu Bio-technology Business Overview
- 4.2.3 Ringpu Bio-technology Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ringpu Bio-technology Animal Parvovirus Vaccine Product Portfolio
- 4.2.5 Ringpu Bio-technology Recent Developments
- 4.3 Qilu Animal Health Products
- 4.3.1 Qilu Animal Health Products Company Information
- 4.3.2 Qilu Animal Health Products Business Overview
- 4.3.3 Qilu Animal Health Products Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qilu Animal Health Products Animal Parvovirus Vaccine Product Portfolio
- 4.3.5 Qilu Animal Health Products Recent Developments
- 4.4 Pulike Biological
- 4.4.1 Pulike Biological Company Information
- 4.4.2 Pulike Biological Business Overview
- 4.4.3 Pulike Biological Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pulike Biological Animal Parvovirus Vaccine Product Portfolio
- 4.4.5 Pulike Biological Recent Developments
- 4.5 Keqian Biology
- 4.5.1 Keqian Biology Company Information
- 4.5.2 Keqian Biology Business Overview
- 4.5.3 Keqian Biology Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Keqian Biology Animal Parvovirus Vaccine Product Portfolio
- 4.5.5 Keqian Biology Recent Developments
- 4.6 Hile Biological
- 4.6.1 Hile Biological Company Information
- 4.6.2 Hile Biological Business Overview
- 4.6.3 Hile Biological Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hile Biological Animal Parvovirus Vaccine Product Portfolio
- 4.6.5 Hile Biological Recent Developments
- 4.7 Harbin Pharmaceutical Group
- 4.7.1 Harbin Pharmaceutical Group Company Information
- 4.7.2 Harbin Pharmaceutical Group Business Overview
- 4.7.3 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Product Portfolio
- 4.7.5 Harbin Pharmaceutical Group Recent Developments
- 4.8 DHN
- 4.8.1 DHN Company Information
- 4.8.2 DHN Business Overview
- 4.8.3 DHN Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 DHN Animal Parvovirus Vaccine Product Portfolio
- 4.8.5 DHN Recent Developments
- 4.9 Zoetis
- 4.9.1 Zoetis Company Information
- 4.9.2 Zoetis Business Overview
- 4.9.3 Zoetis Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zoetis Animal Parvovirus Vaccine Product Portfolio
- 4.9.5 Zoetis Recent Developments
- 4.10 Virbac
- 4.10.1 Virbac Company Information
- 4.10.2 Virbac Business Overview
- 4.10.3 Virbac Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Virbac Animal Parvovirus Vaccine Product Portfolio
- 4.10.5 Virbac Recent Developments
- 4.11 Merck Animal Health
- 4.11.1 Merck Animal Health Company Information
- 4.11.2 Merck Animal Health Business Overview
- 4.11.3 Merck Animal Health Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Merck Animal Health Animal Parvovirus Vaccine Product Portfolio
- 4.11.5 Merck Animal Health Recent Developments
- 4.12 HIPRA
- 4.12.1 HIPRA Company Information
- 4.12.2 HIPRA Business Overview
- 4.12.3 HIPRA Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 HIPRA Animal Parvovirus Vaccine Product Portfolio
- 4.12.5 HIPRA Recent Developments
- 4.13 Elanco
- 4.13.1 Elanco Company Information
- 4.13.2 Elanco Business Overview
- 4.13.3 Elanco Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Elanco Animal Parvovirus Vaccine Product Portfolio
- 4.13.5 Elanco Recent Developments
- 4.14 Ceva Animal Health
- 4.14.1 Ceva Animal Health Company Information
- 4.14.2 Ceva Animal Health Business Overview
- 4.14.3 Ceva Animal Health Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Ceva Animal Health Animal Parvovirus Vaccine Product Portfolio
- 4.14.5 Ceva Animal Health Recent Developments
- 4.15 Boehringer Ingelheim
- 4.15.1 Boehringer Ingelheim Company Information
- 4.15.2 Boehringer Ingelheim Business Overview
- 4.15.3 Boehringer Ingelheim Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Boehringer Ingelheim Animal Parvovirus Vaccine Product Portfolio
- 4.15.5 Boehringer Ingelheim Recent Developments
- 4.16 Bioveta
- 4.16.1 Bioveta Company Information
- 4.16.2 Bioveta Business Overview
- 4.16.3 Bioveta Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Bioveta Animal Parvovirus Vaccine Product Portfolio
- 4.16.5 Bioveta Recent Developments
5 Global Animal Parvovirus Vaccine Market Scenario by Region
- 5.1 Global Animal Parvovirus Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal Parvovirus Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Animal Parvovirus Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Animal Parvovirus Vaccine Sales by Region: 2027-2032
- 5.3 Global Animal Parvovirus Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Animal Parvovirus Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Animal Parvovirus Vaccine Revenue by Region: 2027-2032
- 5.4 North America Animal Parvovirus Vaccine Market Facts & Figures by Country
- 5.4.1 North America Animal Parvovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal Parvovirus Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Animal Parvovirus Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Animal Parvovirus Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Animal Parvovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal Parvovirus Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Animal Parvovirus Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Animal Parvovirus Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal Parvovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal Parvovirus Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal Parvovirus Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal Parvovirus Vaccine Market Facts & Figures by Country
- 5.7.1 South America Animal Parvovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal Parvovirus Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Animal Parvovirus Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Animal Parvovirus Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal Parvovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal Parvovirus Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal Parvovirus Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Animal Parvovirus Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Animal Parvovirus Vaccine Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Animal Parvovirus Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Animal Parvovirus Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Animal Parvovirus Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal Parvovirus Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal Parvovirus Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal Parvovirus Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Animal Parvovirus Vaccine Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Animal Parvovirus Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Animal Parvovirus Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Animal Parvovirus Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal Parvovirus Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal Parvovirus Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal Parvovirus Vaccine Value Chain Analysis
- 8.1.1 Animal Parvovirus Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal Parvovirus Vaccine Production Mode & Process
- 8.2 Animal Parvovirus Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal Parvovirus Vaccine Distributors
- 8.2.3 Animal Parvovirus Vaccine Customers
9 Global Animal Parvovirus Vaccine Analyzing Market Dynamics
- 9.1 Animal Parvovirus Vaccine Industry Trends
- 9.2 Animal Parvovirus Vaccine Industry Drivers
- 9.3 Animal Parvovirus Vaccine Industry Opportunities and Challenges
- 9.4 Animal Parvovirus Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst